[
  {
    "ts": null,
    "headline": "3 Top Dividend Stocks Yielding More Than 3% That You Shouldn't Hesitate to Buy Right Now",
    "summary": "ExxonMobil has the best dividend growth track record in the oil industry.  Johnson & Johnson has increased its dividend for over 60 straight years.  Essex Property Trust has delivered over three decades of dividend increases.",
    "url": "https://finnhub.io/api/news?id=b181e69f3e61e20da091b7ed6997bff0f93a10dd9fd44dc659a4e2a15e877d36",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752703260,
      "headline": "3 Top Dividend Stocks Yielding More Than 3% That You Shouldn't Hesitate to Buy Right Now",
      "id": 135993074,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "ExxonMobil has the best dividend growth track record in the oil industry.  Johnson & Johnson has increased its dividend for over 60 straight years.  Essex Property Trust has delivered over three decades of dividend increases.",
      "url": "https://finnhub.io/api/news?id=b181e69f3e61e20da091b7ed6997bff0f93a10dd9fd44dc659a4e2a15e877d36"
    }
  },
  {
    "ts": null,
    "headline": "S&P 500 Gains & Losses Today: Johnson & Johnson Stock Jumps; Universal Health Services Shares Slide",
    "summary": "The S&P 500 ticked 0.3% higher on Wednesday, July 16, 2025, as President Trump sought to ease concerns that a dismissal of Fed Chair Jerome Powell could be imminent.",
    "url": "https://finnhub.io/api/news?id=b6cc59bb883b1a559bae8bd2ae07a0eafcfa53a42e2074ad1ef525cd643db3f5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752701750,
      "headline": "S&P 500 Gains & Losses Today: Johnson & Johnson Stock Jumps; Universal Health Services Shares Slide",
      "id": 135993145,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The S&P 500 ticked 0.3% higher on Wednesday, July 16, 2025, as President Trump sought to ease concerns that a dismissal of Fed Chair Jerome Powell could be imminent.",
      "url": "https://finnhub.io/api/news?id=b6cc59bb883b1a559bae8bd2ae07a0eafcfa53a42e2074ad1ef525cd643db3f5"
    }
  },
  {
    "ts": null,
    "headline": "Nasdaq Extends Record Run as Trump Denies he Plans to Fire Fed's Powell",
    "summary": "US equities finished higher Wednesday, propelling the Nasdaq Composite to a new high after President",
    "url": "https://finnhub.io/api/news?id=cb22e3c28e05ccb7ecd4c2deb7b2d6d14e963cb4eb98d10c870d68597796ebb7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752700745,
      "headline": "Nasdaq Extends Record Run as Trump Denies he Plans to Fire Fed's Powell",
      "id": 135993146,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "US equities finished higher Wednesday, propelling the Nasdaq Composite to a new high after President",
      "url": "https://finnhub.io/api/news?id=cb22e3c28e05ccb7ecd4c2deb7b2d6d14e963cb4eb98d10c870d68597796ebb7"
    }
  },
  {
    "ts": null,
    "headline": "Stocks to Watch Recap: J&J, UnitedHealth, Goldman Sachs, Ford",
    "summary": "↗️ Johnson & Johnson (JNJ): J&J posted better-than-expected results and boosted its annual outlook. Shares rose 6.2%. ? Goldman Sachs (GS), Bank of America (BAC), Morgan Stanley (MS): The banks reported stronger-than-forecast profits, as tariff-related market turbulence boosted trading.",
    "url": "https://finnhub.io/api/news?id=e2b153ca4d3aff7d5972f5c95d839d832085d6567e756d091107460978a83a6a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752699920,
      "headline": "Stocks to Watch Recap: J&J, UnitedHealth, Goldman Sachs, Ford",
      "id": 135993147,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "↗️ Johnson & Johnson (JNJ): J&J posted better-than-expected results and boosted its annual outlook. Shares rose 6.2%. ? Goldman Sachs (GS), Bank of America (BAC), Morgan Stanley (MS): The banks reported stronger-than-forecast profits, as tariff-related market turbulence boosted trading.",
      "url": "https://finnhub.io/api/news?id=e2b153ca4d3aff7d5972f5c95d839d832085d6567e756d091107460978a83a6a"
    }
  },
  {
    "ts": null,
    "headline": "Health Care Roundup: Market Talk",
    "summary": "Find insight on Novo Nordisk, Praram 9 Hospital, European exporters and more in the latest Market Talks covering Health Care.",
    "url": "https://finnhub.io/api/news?id=076478075d11ab48de1b64589438987ceb49240c8ca425951b614f08b10afd7d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752661680,
      "headline": "Health Care Roundup: Market Talk",
      "id": 135968916,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Find insight on Novo Nordisk, Praram 9 Hospital, European exporters and more in the latest Market Talks covering Health Care.",
      "url": "https://finnhub.io/api/news?id=076478075d11ab48de1b64589438987ceb49240c8ca425951b614f08b10afd7d"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Moved the Most Today: ASML, J&J, Global Payments, Morgan Stanley, Ford, Palantir, Brighthouse, and More",
    "summary": "ASML falls sharply after issuing a growth warning, while Goldman Sachs, Morgan Stanley, and Bank of America post better-than-expected quarterly earnings.",
    "url": "https://finnhub.io/api/news?id=4fecee356d2b1467f121e83354870682bfa3855536c32c12ddfa3e16d2ffd41a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752699000,
      "headline": "These Stocks Moved the Most Today: ASML, J&J, Global Payments, Morgan Stanley, Ford, Palantir, Brighthouse, and More",
      "id": 135993149,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "ASML falls sharply after issuing a growth warning, while Goldman Sachs, Morgan Stanley, and Bank of America post better-than-expected quarterly earnings.",
      "url": "https://finnhub.io/api/news?id=4fecee356d2b1467f121e83354870682bfa3855536c32c12ddfa3e16d2ffd41a"
    }
  },
  {
    "ts": null,
    "headline": "Equity Markets Advance as Trump Denies Plans to Oust Fed Chair Powell",
    "summary": "US benchmark equity indexes closed higher on Wednesday after President Donald Trump refuted claims t",
    "url": "https://finnhub.io/api/news?id=9c04440a78689d2cfa3135ba9e6f9e219849f702610dbf33101c2ecd2bda6208",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752697883,
      "headline": "Equity Markets Advance as Trump Denies Plans to Oust Fed Chair Powell",
      "id": 135993150,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "US benchmark equity indexes closed higher on Wednesday after President Donald Trump refuted claims t",
      "url": "https://finnhub.io/api/news?id=9c04440a78689d2cfa3135ba9e6f9e219849f702610dbf33101c2ecd2bda6208"
    }
  },
  {
    "ts": null,
    "headline": "US Equity Markets Ended Higher Wednesday After President Trump Refuted Rumored Plans to Oust Fed Chair Powell",
    "summary": "US benchmark equity indexes ended higher on Wednesday after stocks swung sharply following reports t",
    "url": "https://finnhub.io/api/news?id=912a629b23371fe015240429538cd7ded709e0d6437f831c1102adbf7768c3b4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752696861,
      "headline": "US Equity Markets Ended Higher Wednesday After President Trump Refuted Rumored Plans to Oust Fed Chair Powell",
      "id": 135993151,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "US benchmark equity indexes ended higher on Wednesday after stocks swung sharply following reports t",
      "url": "https://finnhub.io/api/news?id=912a629b23371fe015240429538cd7ded709e0d6437f831c1102adbf7768c3b4"
    }
  },
  {
    "ts": null,
    "headline": "J&J results a good sign for market, advisor says",
    "summary": "STORY: ASML, the world's biggest supplier of computer chip-making equipment, warned on Wednesday that it may not achieve revenue growth in 2026 as chipmakers building factories in the U.S. await clarity on the potential impact of tariffs.\"What we've got here is a CEO being brutally honest,\" says Miller.\"They really don't know what 2026 is going to look like, so I actually sort of applauded the comment as being so honest in a time when most leaders and most investors are shrugging off the effects of tariffs.\"Meanwhile, Johnson & Johnson shares surged as it halved its expectations for costs this year related to new tariffs and raised its full-year sales and profit forecast after a strong quarter for flagship cancer drug Darzalex and its cardiovascular devices.\"This healthcare sector has really been under a cloud for so many reasons, and these stocks have not performed that well. So here's an opportunity to realize you've got probably a value priced leader in the industry responding to some good results and that's what we want to see as this market broadens out.\"",
    "url": "https://finnhub.io/api/news?id=de425428127c9d30a3fdd63182b22ce096b82f9b095fa072036d8b3620d92446",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752696507,
      "headline": "J&J results a good sign for market, advisor says",
      "id": 135993152,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "STORY: ASML, the world's biggest supplier of computer chip-making equipment, warned on Wednesday that it may not achieve revenue growth in 2026 as chipmakers building factories in the U.S. await clarity on the potential impact of tariffs.\"What we've got here is a CEO being brutally honest,\" says Miller.\"They really don't know what 2026 is going to look like, so I actually sort of applauded the comment as being so honest in a time when most leaders and most investors are shrugging off the effects of tariffs.\"Meanwhile, Johnson & Johnson shares surged as it halved its expectations for costs this year related to new tariffs and raised its full-year sales and profit forecast after a strong quarter for flagship cancer drug Darzalex and its cardiovascular devices.\"This healthcare sector has really been under a cloud for so many reasons, and these stocks have not performed that well. So here's an opportunity to realize you've got probably a value priced leader in the industry responding to some good results and that's what we want to see as this market broadens out.\"",
      "url": "https://finnhub.io/api/news?id=de425428127c9d30a3fdd63182b22ce096b82f9b095fa072036d8b3620d92446"
    }
  },
  {
    "ts": null,
    "headline": "Health Care Up After J&J Earnings - Health Care Roundup",
    "summary": "Health Care Up After J&J Earnings - Health Care Roundup",
    "url": "https://finnhub.io/api/news?id=025d6679b3f61b610534560d917bf665e3c72a529ef6d3e567c41940d0b8cf82",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752688200,
      "headline": "Health Care Up After J&J Earnings - Health Care Roundup",
      "id": 135975024,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Health Care Up After J&J Earnings - Health Care Roundup",
      "url": "https://finnhub.io/api/news?id=025d6679b3f61b610534560d917bf665e3c72a529ef6d3e567c41940d0b8cf82"
    }
  },
  {
    "ts": null,
    "headline": "Dow's J&J Surges; Why Its Report Is Also Bullish For Stryker, Medtronic, Boston Scientific",
    "summary": "Dow's J&J Surges; Why Its Report Is Also Bullish For Stryker, Medtronic, Boston Scientific",
    "url": "https://finnhub.io/api/news?id=79b2516db55454d6b6bab4d5e8f725626ab96989617adc4fc754bdf8ac617918",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752682014,
      "headline": "Dow's J&J Surges; Why Its Report Is Also Bullish For Stryker, Medtronic, Boston Scientific",
      "id": 135975001,
      "image": "",
      "related": "JNJ",
      "source": "DowJones",
      "summary": "Dow's J&J Surges; Why Its Report Is Also Bullish For Stryker, Medtronic, Boston Scientific",
      "url": "https://finnhub.io/api/news?id=79b2516db55454d6b6bab4d5e8f725626ab96989617adc4fc754bdf8ac617918"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson (JNJ) Q2 2025 Earnings Call Transcript",
    "summary": "Johnson & Johnson (JNJ) Q2 2025 Earnings Call Transcript",
    "url": "https://finnhub.io/api/news?id=a5cd65e0685e0b14afb27bbead004c98ab851afbe021fc1c5c652d09f2bb22fa",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752680166,
      "headline": "Johnson & Johnson (JNJ) Q2 2025 Earnings Call Transcript",
      "id": 135970571,
      "image": "",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=a5cd65e0685e0b14afb27bbead004c98ab851afbe021fc1c5c652d09f2bb22fa"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson, Amgen share gains lead Dow's 229-point jump",
    "summary": "Johnson & Johnson, Amgen share gains lead Dow's 229-point jump",
    "url": "https://finnhub.io/api/news?id=d4782c7b39a8beb3653018a7c1d810e0f711de118ad25008a0c5294e6bc8e4ba",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752678060,
      "headline": "Johnson & Johnson, Amgen share gains lead Dow's 229-point jump",
      "id": 135974786,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Johnson & Johnson, Amgen share gains lead Dow's 229-point jump",
      "url": "https://finnhub.io/api/news?id=d4782c7b39a8beb3653018a7c1d810e0f711de118ad25008a0c5294e6bc8e4ba"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street ends up, after brief downward detour on Powell firing confusion",
    "summary": "Wall Street benchmarks closedmodestly higher on Wednesday, with the Nasdaq Compositeachieving its latest record finish, despite a chaotic half hourwhen news reports suggested U.S. President Donald...",
    "url": "https://finnhub.io/api/news?id=4fe1dff78e5a57392a52e47a6d3abbd298e203c635e3fcba68d13b86734d4c9f",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752678013,
      "headline": "Wall Street ends up, after brief downward detour on Powell firing confusion",
      "id": 135971074,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Wall Street benchmarks closedmodestly higher on Wednesday, with the Nasdaq Compositeachieving its latest record finish, despite a chaotic half hourwhen news reports suggested U.S. President Donald...",
      "url": "https://finnhub.io/api/news?id=4fe1dff78e5a57392a52e47a6d3abbd298e203c635e3fcba68d13b86734d4c9f"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street ends higher after brief slump on Powell firing confusion",
    "summary": "Wall Street benchmarks endedmodestly higher on Wednesday, with the Nasdaq Composite postingits latest record finish, despite a chaotic half hour when newsreports suggested U.S. President Donald...",
    "url": "https://finnhub.io/api/news?id=35062f75df34d0afcf1c55f01969e6aeda8c4c39ba64c93efa8d24ed52ff95fa",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752678013,
      "headline": "Wall Street ends higher after brief slump on Powell firing confusion",
      "id": 135970703,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Wall Street benchmarks endedmodestly higher on Wednesday, with the Nasdaq Composite postingits latest record finish, despite a chaotic half hour when newsreports suggested U.S. President Donald...",
      "url": "https://finnhub.io/api/news?id=35062f75df34d0afcf1c55f01969e6aeda8c4c39ba64c93efa8d24ed52ff95fa"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson 2025 Q2 - Results - Earnings Call Presentation",
    "summary": "Johnson & Johnson 2025 Q2 - Results - Earnings Call Presentation",
    "url": "https://finnhub.io/api/news?id=c4e1dbc97d219ee770501c95218165ad5c3362d236fbd7319a351f79044f7ab8",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752676317,
      "headline": "Johnson & Johnson 2025 Q2 - Results - Earnings Call Presentation",
      "id": 135970310,
      "image": "",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=c4e1dbc97d219ee770501c95218165ad5c3362d236fbd7319a351f79044f7ab8"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street Lunch: Goldman Trading Desk Got Its Mojo Workin'",
    "summary": "Wall Street Lunch: Goldman Trading Desk Got Its Mojo Workin'",
    "url": "https://finnhub.io/api/news?id=f7f1445f26aa77da65bad3b35622814ffcc5f2081490cc747051c3b0befa26b3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752675300,
      "headline": "Wall Street Lunch: Goldman Trading Desk Got Its Mojo Workin'",
      "id": 135970193,
      "image": "",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=f7f1445f26aa77da65bad3b35622814ffcc5f2081490cc747051c3b0befa26b3"
    }
  },
  {
    "ts": null,
    "headline": "Dow's 110-point rally highlighted by gains in Johnson & Johnson, Amgen shares",
    "summary": "Dow's 110-point rally highlighted by gains in Johnson & Johnson, Amgen shares",
    "url": "https://finnhub.io/api/news?id=a0c81a2e1a73797074931abfc01958c4341d0c935e5e325e610922e39e6cc95d",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752670980,
      "headline": "Dow's 110-point rally highlighted by gains in Johnson & Johnson, Amgen shares",
      "id": 135974788,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Dow's 110-point rally highlighted by gains in Johnson & Johnson, Amgen shares",
      "url": "https://finnhub.io/api/news?id=a0c81a2e1a73797074931abfc01958c4341d0c935e5e325e610922e39e6cc95d"
    }
  },
  {
    "ts": null,
    "headline": "Looming Tariffs Don't Scare This Swiss Cancer Treatment Stock",
    "summary": "Looming Tariffs Don't Scare This Swiss Cancer Treatment Stock",
    "url": "https://finnhub.io/api/news?id=8cbfa1cfa5cd8b6d523a145d3fe5c9399c8e92a0b20bdbe195c9239e6d7812a7",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752670648,
      "headline": "Looming Tariffs Don't Scare This Swiss Cancer Treatment Stock",
      "id": 135975003,
      "image": "",
      "related": "JNJ",
      "source": "DowJones",
      "summary": "Looming Tariffs Don't Scare This Swiss Cancer Treatment Stock",
      "url": "https://finnhub.io/api/news?id=8cbfa1cfa5cd8b6d523a145d3fe5c9399c8e92a0b20bdbe195c9239e6d7812a7"
    }
  },
  {
    "ts": null,
    "headline": "J&J Raises Full-Year Outlook After Beating Profit Expectations",
    "summary": "J&J Raises Full-Year Outlook After Beating Profit Expectations",
    "url": "https://finnhub.io/api/news?id=1840e41ce88f811f76597b092f2d2f0d79cd46d25a10cb8f93fd8d40d6a9b523",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752670260,
      "headline": "J&J Raises Full-Year Outlook After Beating Profit Expectations",
      "id": 135975005,
      "image": "",
      "related": "JNJ",
      "source": "DowJones",
      "summary": "J&J Raises Full-Year Outlook After Beating Profit Expectations",
      "url": "https://finnhub.io/api/news?id=1840e41ce88f811f76597b092f2d2f0d79cd46d25a10cb8f93fd8d40d6a9b523"
    }
  },
  {
    "ts": null,
    "headline": "J&J Raises Full-Year Outlook After Beating 2Q Expectations -- Update",
    "summary": "By Kelly Cloonan Johnson & Johnson boosted its full-year outlook as it factors in a lower impact from tariffs and posted a better-than-expected profit and sales in the second quarter. The...",
    "url": "https://finnhub.io/api/news?id=fe7c55c457992819a5be17a20c5aa4944d437e120a3827d71b482e69c3e4a939",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752670088,
      "headline": "J&J Raises Full-Year Outlook After Beating 2Q Expectations -- Update",
      "id": 135969773,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "By Kelly Cloonan Johnson & Johnson boosted its full-year outlook as it factors in a lower impact from tariffs and posted a better-than-expected profit and sales in the second quarter. The...",
      "url": "https://finnhub.io/api/news?id=fe7c55c457992819a5be17a20c5aa4944d437e120a3827d71b482e69c3e4a939"
    }
  },
  {
    "ts": null,
    "headline": "Dow Health Giant J&J Surges After Hiking Outlook On Strong Quarterly Report",
    "summary": "Johnson & Johnson stock jumped early Wednesday after the health care giant beat second-quarter forecasts and raised its outlook.",
    "url": "https://finnhub.io/api/news?id=0347e042196369e13e78c016185a6b597d94c5a9b3e019ffc585c31136398e04",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752669923,
      "headline": "Dow Health Giant J&J Surges After Hiking Outlook On Strong Quarterly Report",
      "id": 135964981,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson stock jumped early Wednesday after the health care giant beat second-quarter forecasts and raised its outlook.",
      "url": "https://finnhub.io/api/news?id=0347e042196369e13e78c016185a6b597d94c5a9b3e019ffc585c31136398e04"
    }
  },
  {
    "ts": null,
    "headline": "Trump Threatens Pharma Tariffs Soon. Why the Stocks Are Looking Healthy.",
    "summary": "Trump Threatens Pharma Tariffs Soon. Why the Stocks Are Looking Healthy.",
    "url": "https://finnhub.io/api/news?id=97ab44abf5ee1b1e0d567b77c8e08918c45866d82561979061d15f1dab32bc80",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752669900,
      "headline": "Trump Threatens Pharma Tariffs Soon. Why the Stocks Are Looking Healthy.",
      "id": 135975027,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Trump Threatens Pharma Tariffs Soon. Why the Stocks Are Looking Healthy.",
      "url": "https://finnhub.io/api/news?id=97ab44abf5ee1b1e0d567b77c8e08918c45866d82561979061d15f1dab32bc80"
    }
  },
  {
    "ts": null,
    "headline": "Stock Market Today: Indexes Rise On Surprise Inflation Data; ASML Plunges On This Warning (Live Coverage)",
    "summary": "Futures on the Dow Jones Industrial Average and other major indexes were mostly higher Wednesday, as Wall Street digested cooler-than-expected inflation data. Meanwhile, chip stock ASML plunged on the stock market today after the company warned it couldn't guarantee growth in 2026 due to tariff uncertainty.",
    "url": "https://finnhub.io/api/news?id=7192c8ea8025821fa91fbb5a024606ddd592c65682fe5a185c65a4f69881172a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752669726,
      "headline": "Stock Market Today: Indexes Rise On Surprise Inflation Data; ASML Plunges On This Warning (Live Coverage)",
      "id": 135964982,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Futures on the Dow Jones Industrial Average and other major indexes were mostly higher Wednesday, as Wall Street digested cooler-than-expected inflation data. Meanwhile, chip stock ASML plunged on the stock market today after the company warned it couldn't guarantee growth in 2026 due to tariff uncertainty.",
      "url": "https://finnhub.io/api/news?id=7192c8ea8025821fa91fbb5a024606ddd592c65682fe5a185c65a4f69881172a"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Lifts Annual Forecast After Strong Cancer Drugs, Medtech Performance",
    "summary": "Johnson & Johnson (NYSE:JNJ) on Wednesday reported a second-quarter 2025 adjusted earnings of $2.77 per share, down 1.8% year over year, beating the consensus of $2.68. The pharmaceutical giant reported sales of $23.74 billion, up 5.8% year over year and beating the consensus of $22.85 billion. Operational growth was 4.6%, and adjusted operational growth was 3%. Innovative Medicine sales increased 4.9% or 3.8% operationally to $15.20 billion. Also Read: Johnson & Johnson’s Drug Discount Plan Get",
    "url": "https://finnhub.io/api/news?id=c69bb55ea1197943d82a5e410635cea92241936e48699466c65dddb77def2b87",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752669702,
      "headline": "Johnson & Johnson Lifts Annual Forecast After Strong Cancer Drugs, Medtech Performance",
      "id": 135964983,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (NYSE:JNJ) on Wednesday reported a second-quarter 2025 adjusted earnings of $2.77 per share, down 1.8% year over year, beating the consensus of $2.68. The pharmaceutical giant reported sales of $23.74 billion, up 5.8% year over year and beating the consensus of $22.85 billion. Operational growth was 4.6%, and adjusted operational growth was 3%. Innovative Medicine sales increased 4.9% or 3.8% operationally to $15.20 billion. Also Read: Johnson & Johnson’s Drug Discount Plan Get",
      "url": "https://finnhub.io/api/news?id=c69bb55ea1197943d82a5e410635cea92241936e48699466c65dddb77def2b87"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson’s stock surges as tariff-cost estimate is slashed and profit outlook raised",
    "summary": "Johnson & Johnson’s stock surges as tariff-cost estimate is slashed and profit outlook raised",
    "url": "https://finnhub.io/api/news?id=5173fc0929b99db94fd58656c5ddddc0ccafbadceecf5e19adb775a71e309b49",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752668760,
      "headline": "Johnson & Johnson’s stock surges as tariff-cost estimate is slashed and profit outlook raised",
      "id": 135975028,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Johnson & Johnson’s stock surges as tariff-cost estimate is slashed and profit outlook raised",
      "url": "https://finnhub.io/api/news?id=5173fc0929b99db94fd58656c5ddddc0ccafbadceecf5e19adb775a71e309b49"
    }
  },
  {
    "ts": null,
    "headline": "Stocks to Watch Wednesday: J&J, Bank of America, UnitedHealth, Goldman",
    "summary": "↗️ Johnson & Johnson (JNJ): J&J boosted its annual outlook, after posting better-than-expected quarterly profit and sales. Shares rose nearly 2% in premarket trading. ↗️ Goldman Sachs (GS): The Wall Street bank reported a stronger-than-expected quarterly profit, fueled by a pickup in dealmaking and surging trading during tariff-driven market turmoil.",
    "url": "https://finnhub.io/api/news?id=0d74486a509df0a877ba382fef42875b59cc83c326422e6954b9a70c08187840",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752668750,
      "headline": "Stocks to Watch Wednesday: J&J, Bank of America, UnitedHealth, Goldman",
      "id": 135964984,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "↗️ Johnson & Johnson (JNJ): J&J boosted its annual outlook, after posting better-than-expected quarterly profit and sales. Shares rose nearly 2% in premarket trading. ↗️ Goldman Sachs (GS): The Wall Street bank reported a stronger-than-expected quarterly profit, fueled by a pickup in dealmaking and surging trading during tariff-driven market turmoil.",
      "url": "https://finnhub.io/api/news?id=0d74486a509df0a877ba382fef42875b59cc83c326422e6954b9a70c08187840"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Are Moving the Most Today: Nvidia, ASML, J&J, Bank of America, Goldman, Palantir, Brighthouse, and More",
    "summary": "ASML falls sharply after issuing a growth warning, while Goldman Sachs, Morgan Stanley, and Bank of America post better-than-expected quarterly earnings.",
    "url": "https://finnhub.io/api/news?id=6e8a63bb59abc97b16c5fb24f54f1258da9c7ff6a346c7db56ae0c0522d81f48",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752666600,
      "headline": "These Stocks Are Moving the Most Today: Nvidia, ASML, J&J, Bank of America, Goldman, Palantir, Brighthouse, and More",
      "id": 135964641,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "ASML falls sharply after issuing a growth warning, while Goldman Sachs, Morgan Stanley, and Bank of America post better-than-expected quarterly earnings.",
      "url": "https://finnhub.io/api/news?id=6e8a63bb59abc97b16c5fb24f54f1258da9c7ff6a346c7db56ae0c0522d81f48"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson outlook, MP Materials surges: Trending Tickers",
    "summary": "Johnson & Johnson (JNJ) shares tick higher in pre-market trading after the company raised its full-year earnings and sales guidance, though looming pharmaceutical tariffs from President Trump remain a key risk for the sector. MP Materials (MP) stock jumped after Apple (AAPL) announced a $500 million deal to buy rare earth magnets and build a rare earth recycling facility in California. To watch more expert insights and analysis on the latest market action, check out more Morning Brief: Market Sunrise here.",
    "url": "https://finnhub.io/api/news?id=e0b7f84b6b2748e5c9fb93cbadf73b813b6cc5efc218ccfbb33e8c9a9481c968",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752666341,
      "headline": "Johnson & Johnson outlook, MP Materials surges: Trending Tickers",
      "id": 135964676,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (JNJ) shares tick higher in pre-market trading after the company raised its full-year earnings and sales guidance, though looming pharmaceutical tariffs from President Trump remain a key risk for the sector. MP Materials (MP) stock jumped after Apple (AAPL) announced a $500 million deal to buy rare earth magnets and build a rare earth recycling facility in California. To watch more expert insights and analysis on the latest market action, check out more Morning Brief: Market Sunrise here.",
      "url": "https://finnhub.io/api/news?id=e0b7f84b6b2748e5c9fb93cbadf73b813b6cc5efc218ccfbb33e8c9a9481c968"
    }
  },
  {
    "ts": null,
    "headline": "5 Things to Know Before the Stock Market Opens",
    "summary": "News of the day for July 16, 2025",
    "url": "https://finnhub.io/api/news?id=d2270f73b56256c79cb6baee74ae316f87fafb44d80c953b6e693c8b8e30660c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752666231,
      "headline": "5 Things to Know Before the Stock Market Opens",
      "id": 135964987,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "News of the day for July 16, 2025",
      "url": "https://finnhub.io/api/news?id=d2270f73b56256c79cb6baee74ae316f87fafb44d80c953b6e693c8b8e30660c"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Reports Earnings Results for the Second Quarter and Six Months Ended June 29, 2025",
    "summary": "Johnson & Johnson reported earnings results for the second quarter and six months ended June 29, 2025. For the second quarter, the company reported sales was USD 23,743 million compared to USD 22,447...",
    "url": "https://finnhub.io/api/news?id=177992d1f14a1b5e07c638d6a47829ed01016ff25ca2aaa107788f7cdd9670a1",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752665864,
      "headline": "Johnson & Johnson Reports Earnings Results for the Second Quarter and Six Months Ended June 29, 2025",
      "id": 135969257,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Johnson & Johnson reported earnings results for the second quarter and six months ended June 29, 2025. For the second quarter, the company reported sales was USD 23,743 million compared to USD 22,447...",
      "url": "https://finnhub.io/api/news?id=177992d1f14a1b5e07c638d6a47829ed01016ff25ca2aaa107788f7cdd9670a1"
    }
  },
  {
    "ts": null,
    "headline": "Transcript : Johnson & Johnson, Q2 2025 Earnings Call, Jul 16, 2025",
    "summary": "Presentation Operator MessageOperator Good morning, and welcome to Johnson & Johnson's Second Quarter 202 Earnings Conference Call. [Operator Instructions] This call is being recorded. I will now turn...",
    "url": "https://finnhub.io/api/news?id=3bbb96780a31287779180c514d4bf63b20c08824d5228b763a3c89ef309fa449",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752665840,
      "headline": "Transcript : Johnson & Johnson, Q2 2025 Earnings Call, Jul 16, 2025",
      "id": 135969230,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Presentation Operator MessageOperator Good morning, and welcome to Johnson & Johnson's Second Quarter 202 Earnings Conference Call. [Operator Instructions] This call is being recorded. I will now turn...",
      "url": "https://finnhub.io/api/news?id=3bbb96780a31287779180c514d4bf63b20c08824d5228b763a3c89ef309fa449"
    }
  },
  {
    "ts": null,
    "headline": "J&J second quarter earnings beat Wall Street estimates, stock  up on increased 2025 guidance",
    "summary": "J&J reported second quarter earnings Tuesday. The company is under scrutiny by investors as it faces drug patent cliffs.",
    "url": "https://finnhub.io/api/news?id=b8ebf94adbb65a09a34ba28de622cffa57b1afc6a89617a4344aeed49f521814",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752665184,
      "headline": "J&J second quarter earnings beat Wall Street estimates, stock  up on increased 2025 guidance",
      "id": 135964988,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "J&J reported second quarter earnings Tuesday. The company is under scrutiny by investors as it faces drug patent cliffs.",
      "url": "https://finnhub.io/api/news?id=b8ebf94adbb65a09a34ba28de622cffa57b1afc6a89617a4344aeed49f521814"
    }
  },
  {
    "ts": null,
    "headline": "Stocks Mostly Down Pre-Bell as Traders Await Producer Prices Data, More Bank Earnings",
    "summary": "The main US stock measures were mostly trending downwards in Wednesday's premarket activity, as inve",
    "url": "https://finnhub.io/api/news?id=eb803f551884b713da9d5a3b2da0ca5507f3eb3bf4809089bc30125415533c84",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752665111,
      "headline": "Stocks Mostly Down Pre-Bell as Traders Await Producer Prices Data, More Bank Earnings",
      "id": 135964989,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The main US stock measures were mostly trending downwards in Wednesday's premarket activity, as inve",
      "url": "https://finnhub.io/api/news?id=eb803f551884b713da9d5a3b2da0ca5507f3eb3bf4809089bc30125415533c84"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Tops Q2 Estimates, Lifts Outlook for Sales and Profit",
    "summary": "Johnson & Johnson on Wednesday reported second quarter results that topped estimates and the company lifted its full-year outlook.",
    "url": "https://finnhub.io/api/news?id=dab7adcff2fb4fd8e29622e93163017f371abb35ddfea3c33a956048b91fdfdb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752664521,
      "headline": "Johnson & Johnson Tops Q2 Estimates, Lifts Outlook for Sales and Profit",
      "id": 135964991,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson on Wednesday reported second quarter results that topped estimates and the company lifted its full-year outlook.",
      "url": "https://finnhub.io/api/news?id=dab7adcff2fb4fd8e29622e93163017f371abb35ddfea3c33a956048b91fdfdb"
    }
  },
  {
    "ts": null,
    "headline": "Earnings, Inflation Outlook Damp Wall Street Pre-Bell; Asia Mixed, Europe Flat",
    "summary": "Wall Street futures pointed modestly lower pre-bell Wednesday as traders awaited another inflation r",
    "url": "https://finnhub.io/api/news?id=fedd330cc84552f2cd4124c8406fc44ec5ed49f7d56252671f2891aa4d7ed0d1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752664313,
      "headline": "Earnings, Inflation Outlook Damp Wall Street Pre-Bell; Asia Mixed, Europe Flat",
      "id": 135964992,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Wall Street futures pointed modestly lower pre-bell Wednesday as traders awaited another inflation r",
      "url": "https://finnhub.io/api/news?id=fedd330cc84552f2cd4124c8406fc44ec5ed49f7d56252671f2891aa4d7ed0d1"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Q2 Earnings Review: This Is As Safe As Pharma Investing Gets",
    "summary": "Johnson & Johnson shows steady growth in Q2, driven by medtech and oncology, yet talc litigation overshadows. Click for my JNJ earnings update.",
    "url": "https://finnhub.io/api/news?id=a594a173bc9ecc736739ba1cba4a05096248d9c9d8c7022d549a3275305b6ab9",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752663831,
      "headline": "Johnson & Johnson Q2 Earnings Review: This Is As Safe As Pharma Investing Gets",
      "id": 135968725,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1180491673/image_1180491673.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Johnson & Johnson shows steady growth in Q2, driven by medtech and oncology, yet talc litigation overshadows. Click for my JNJ earnings update.",
      "url": "https://finnhub.io/api/news?id=a594a173bc9ecc736739ba1cba4a05096248d9c9d8c7022d549a3275305b6ab9"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson leads S&P 500 and Dow",
    "summary": "Johnson & Johnson leads S&P 500 and Dow",
    "url": "https://finnhub.io/api/news?id=f3254fcda6325fe9aff6b9f84ea9ebf50972af992b5291d53ab0876f545ab07f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752662510,
      "headline": "Johnson & Johnson leads S&P 500 and Dow",
      "id": 135975029,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Johnson & Johnson leads S&P 500 and Dow",
      "url": "https://finnhub.io/api/news?id=f3254fcda6325fe9aff6b9f84ea9ebf50972af992b5291d53ab0876f545ab07f"
    }
  },
  {
    "ts": null,
    "headline": "Trump Threatens Pharma Tariffs This Month. Why the Stocks Are Looking Healthy.",
    "summary": "Trump has again threatened the multibillion-dollar pharmaceutical sector with high tariffs unless they move production to the U.S.",
    "url": "https://finnhub.io/api/news?id=448f593dcc2fcaff7ce0f76ae6948953b4e572c7fe3374e6435eac06eeae5e30",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752662100,
      "headline": "Trump Threatens Pharma Tariffs This Month. Why the Stocks Are Looking Healthy.",
      "id": 135964841,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Trump has again threatened the multibillion-dollar pharmaceutical sector with high tariffs unless they move production to the U.S.",
      "url": "https://finnhub.io/api/news?id=448f593dcc2fcaff7ce0f76ae6948953b4e572c7fe3374e6435eac06eeae5e30"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Beats Earnings Estimates. Financial Chief Says It Can Do Any Deal It Wants.",
    "summary": "The company reports adjusted earnings of $2.77 a share for the second quarter, beating analysts’ estimates of $2.68.",
    "url": "https://finnhub.io/api/news?id=3f3f410625cfaa69623678ffacef5b32db5d27adedf60cd8e82b6189896df95d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752661920,
      "headline": "Johnson & Johnson Beats Earnings Estimates. Financial Chief Says It Can Do Any Deal It Wants.",
      "id": 135964994,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The company reports adjusted earnings of $2.77 a share for the second quarter, beating analysts’ estimates of $2.68.",
      "url": "https://finnhub.io/api/news?id=3f3f410625cfaa69623678ffacef5b32db5d27adedf60cd8e82b6189896df95d"
    }
  },
  {
    "ts": null,
    "headline": "Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2025",
    "summary": "Company Announcement Net sales of DARZALEX® in the second quarter of 2025 totaled USD 3,539 millionGenmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech, Inc.) COPENHAGEN, Denmark; July 16, 2025 – Genmab A/S (Nasdaq: GMAB) announced today that worldwide net trade sales of DARZALEX (daratumumab), including sales of the subcutaneous (SC) product (daratumumab and hyaluronidase-fihj, sold under the tradename DARZALEX FASPRO® in the U.S.), as repor",
    "url": "https://finnhub.io/api/news?id=c27f00d01924349033dd0f7011543b4d11d502687d0cdadfb7fb3ff107bb7d77",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752661740,
      "headline": "Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2025",
      "id": 135964996,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Company Announcement Net sales of DARZALEX® in the second quarter of 2025 totaled USD 3,539 millionGenmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech, Inc.) COPENHAGEN, Denmark; July 16, 2025 – Genmab A/S (Nasdaq: GMAB) announced today that worldwide net trade sales of DARZALEX (daratumumab), including sales of the subcutaneous (SC) product (daratumumab and hyaluronidase-fihj, sold under the tradename DARZALEX FASPRO® in the U.S.), as repor",
      "url": "https://finnhub.io/api/news?id=c27f00d01924349033dd0f7011543b4d11d502687d0cdadfb7fb3ff107bb7d77"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson: Q2 Earnings Snapshot",
    "summary": "NEW BRUNSWICK, N.J. (AP) — Johnson & Johnson (JNJ) on Wednesday reported second-quarter earnings of $5.54 billion. The New Brunswick, New Jersey-based company said it had profit of $2.29 per share. Earnings, adjusted for one-time gains and costs, came to $2.77 per share.",
    "url": "https://finnhub.io/api/news?id=704cb8db6261e3d91616e1938f4d81817998e27aba46a0ac2293ea3d5d03a927",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752661653,
      "headline": "Johnson & Johnson: Q2 Earnings Snapshot",
      "id": 135964998,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "NEW BRUNSWICK, N.J. (AP) — Johnson & Johnson (JNJ) on Wednesday reported second-quarter earnings of $5.54 billion. The New Brunswick, New Jersey-based company said it had profit of $2.29 per share. Earnings, adjusted for one-time gains and costs, came to $2.77 per share.",
      "url": "https://finnhub.io/api/news?id=704cb8db6261e3d91616e1938f4d81817998e27aba46a0ac2293ea3d5d03a927"
    }
  },
  {
    "ts": null,
    "headline": "J&J Raises Full-Year Outlook After Beating  Profit Expectations",
    "summary": "Johnson & Johnson boosted its full-year outlook as it posted better-than-expected profit and sales in the second quarter.",
    "url": "https://finnhub.io/api/news?id=c99d3640c8186790b6daa6fc32ae4f9d989fe729702a521a213cc492e5ba1e40",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752661620,
      "headline": "J&J Raises Full-Year Outlook After Beating  Profit Expectations",
      "id": 135965000,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson boosted its full-year outlook as it posted better-than-expected profit and sales in the second quarter.",
      "url": "https://finnhub.io/api/news?id=c99d3640c8186790b6daa6fc32ae4f9d989fe729702a521a213cc492e5ba1e40"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson beats profit estimates on strong Darzalex, medtech sales",
    "summary": "(Reuters) -Johnson & Johnson raised its full-year sales forecast on Wednesday after beating estimates for second-quarter profit on strong demand for its cancer drug, Darzalex, and strength in its medical device business.  The company also reduced its expectations for tariff-related costs to $200 million from $400 million for the year, citing the Trump administration's pause on levies on China and other retaliatory tariff measures.  \"We were able to absorb that and still raise our EPS guidance by 25 cents on the year,\" CFO Joseph Wolk said.",
    "url": "https://finnhub.io/api/news?id=f22717ab06c262259fd1fb201044b0e2d68334a726ee61d6449a40acb21cac17",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752661611,
      "headline": "Johnson & Johnson beats profit estimates on strong Darzalex, medtech sales",
      "id": 135965002,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "(Reuters) -Johnson & Johnson raised its full-year sales forecast on Wednesday after beating estimates for second-quarter profit on strong demand for its cancer drug, Darzalex, and strength in its medical device business.  The company also reduced its expectations for tariff-related costs to $200 million from $400 million for the year, citing the Trump administration's pause on levies on China and other retaliatory tariff measures.  \"We were able to absorb that and still raise our EPS guidance by 25 cents on the year,\" CFO Joseph Wolk said.",
      "url": "https://finnhub.io/api/news?id=f22717ab06c262259fd1fb201044b0e2d68334a726ee61d6449a40acb21cac17"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson shrugs off tariff impact and forecasts sales boost",
    "summary": "Johnson & Johnson has shrugged off the impact of tariffs as the US-based healthcare group raised its earnings and sales guidance for 2025. J...",
    "url": "https://finnhub.io/api/news?id=682785971e5c5fd91bbbdc36c049d3f2dd070d4a886b35947d140bf1cc92d0a8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752661507,
      "headline": "Johnson & Johnson shrugs off tariff impact and forecasts sales boost",
      "id": 135965004,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson has shrugged off the impact of tariffs as the US-based healthcare group raised its earnings and sales guidance for 2025. J...",
      "url": "https://finnhub.io/api/news?id=682785971e5c5fd91bbbdc36c049d3f2dd070d4a886b35947d140bf1cc92d0a8"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2025",
    "summary": "NEW BRUNSWICK, N.J., July 16, 2025--Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the third quarter of 2025 of $1.30 per share on the company’s common stock. The dividend is payable on September 9, 2025 to shareholders of record at the close of business on August 26, 2025. The ex-dividend date is August 26, 2025.",
    "url": "https://finnhub.io/api/news?id=0137a13f833ff8c1daddd7b2c77813d439d22bea065975b15169fa8fc91f7da3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752661500,
      "headline": "Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2025",
      "id": 135965006,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "NEW BRUNSWICK, N.J., July 16, 2025--Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the third quarter of 2025 of $1.30 per share on the company’s common stock. The dividend is payable on September 9, 2025 to shareholders of record at the close of business on August 26, 2025. The ex-dividend date is August 26, 2025.",
      "url": "https://finnhub.io/api/news?id=0137a13f833ff8c1daddd7b2c77813d439d22bea065975b15169fa8fc91f7da3"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Reports Q2 2025 Results; Raises 2025 Outlook",
    "summary": "NEW BRUNSWICK, N.J., July 16, 2025--Johnson & Johnson (NYSE: JNJ) today announced results for second-quarter 2025. \"Today’s strong results reflect the depth and strength of Johnson & Johnson’s uniquely diversified business operating across both MedTech and Innovative Medicine,\" said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & Johnson. \"Our portfolio and pipeline position us for elevated growth in the second half of the year, with game-changing approvals and submissions anticip",
    "url": "https://finnhub.io/api/news?id=6ce9af77dbdbe6515d00588bb6dbbda412990a4c449d0c27762be1741e93443c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752661200,
      "headline": "Johnson & Johnson Reports Q2 2025 Results; Raises 2025 Outlook",
      "id": 135965008,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "NEW BRUNSWICK, N.J., July 16, 2025--Johnson & Johnson (NYSE: JNJ) today announced results for second-quarter 2025. \"Today’s strong results reflect the depth and strength of Johnson & Johnson’s uniquely diversified business operating across both MedTech and Innovative Medicine,\" said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & Johnson. \"Our portfolio and pipeline position us for elevated growth in the second half of the year, with game-changing approvals and submissions anticip",
      "url": "https://finnhub.io/api/news?id=6ce9af77dbdbe6515d00588bb6dbbda412990a4c449d0c27762be1741e93443c"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street steadies as investors assess inflation data, earnings",
    "summary": "* Indexes: Dow up 0.10%, S&P 500 up 0.03%, Nasdaq down 0.12% ...",
    "url": "https://finnhub.io/api/news?id=7f4f3f41e36157823a1d13a08c0a20ba5baf0f3cdc8b021ccaa7c21bd8cecd30",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752661098,
      "headline": "Wall Street steadies as investors assess inflation data, earnings",
      "id": 135967688,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "* Indexes: Dow up 0.10%, S&P 500 up 0.03%, Nasdaq down 0.12% ...",
      "url": "https://finnhub.io/api/news?id=7f4f3f41e36157823a1d13a08c0a20ba5baf0f3cdc8b021ccaa7c21bd8cecd30"
    }
  },
  {
    "ts": null,
    "headline": "J&J says 2025 forecast does not include impact of Most Favored Nation drug pricing",
    "summary": "Johnson & Johnson: J&J exec says 2025 forecast does not include impact of Most Favored Nation drug pricing - conf call J&J exec says continue to monitor what the future year's impact could be...",
    "url": "https://finnhub.io/api/news?id=60aab2b3f9332b0b43ae37058cf4eadb11bd9301f15f406933161b71e6eb1788",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752659170,
      "headline": "J&J says 2025 forecast does not include impact of Most Favored Nation drug pricing",
      "id": 135967015,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Johnson & Johnson: J&J exec says 2025 forecast does not include impact of Most Favored Nation drug pricing - conf call J&J exec says continue to monitor what the future year's impact could be...",
      "url": "https://finnhub.io/api/news?id=60aab2b3f9332b0b43ae37058cf4eadb11bd9301f15f406933161b71e6eb1788"
    }
  },
  {
    "ts": null,
    "headline": "3 Flaws Of Dividend Investing That Limit Returns",
    "summary": "3 Flaws Of Dividend Investing That Limit Returns",
    "url": "https://finnhub.io/api/news?id=b195ba6ea0a5e872d6062ee24448200cf30769971fe336e7963f9b32a788be7c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752658200,
      "headline": "3 Flaws Of Dividend Investing That Limit Returns",
      "id": 135966823,
      "image": "",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=b195ba6ea0a5e872d6062ee24448200cf30769971fe336e7963f9b32a788be7c"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Beats Earnings Estimates. CFO Says It Can Do Any Deal It Wants.",
    "summary": "Johnson & Johnson Beats Earnings Estimates. CFO Says It Can Do Any Deal It Wants.",
    "url": "https://finnhub.io/api/news?id=de5a2772f9d599ce49eb8fa27e5abaf58fc4876e464cdf1f9819e662eeb19feb",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752658020,
      "headline": "Johnson & Johnson Beats Earnings Estimates. CFO Says It Can Do Any Deal It Wants.",
      "id": 135975030,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Johnson & Johnson Beats Earnings Estimates. CFO Says It Can Do Any Deal It Wants.",
      "url": "https://finnhub.io/api/news?id=de5a2772f9d599ce49eb8fa27e5abaf58fc4876e464cdf1f9819e662eeb19feb"
    }
  },
  {
    "ts": null,
    "headline": "S&P 500, Dow set for higher start as inflation data, earnings take center stage",
    "summary": "* Futures up: Dow 0.38%, S&P 500 0.21%, Nasdaq 0.07% * Bank of America profit rises, shares gain * Johnson & Johnson up as Q2 profit beats...",
    "url": "https://finnhub.io/api/news?id=a77f631e1bc79ed645de558edeb7700bea78c390bf45f2eff0d2309b0fae3197",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752656903,
      "headline": "S&P 500, Dow set for higher start as inflation data, earnings take center stage",
      "id": 135965475,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "* Futures up: Dow 0.38%, S&P 500 0.21%, Nasdaq 0.07% * Bank of America profit rises, shares gain * Johnson & Johnson up as Q2 profit beats...",
      "url": "https://finnhub.io/api/news?id=a77f631e1bc79ed645de558edeb7700bea78c390bf45f2eff0d2309b0fae3197"
    }
  },
  {
    "ts": null,
    "headline": "US stocks hold near all-time highs after a better-than-expected update on inflation",
    "summary": "NEW YORK — U.S. stock indexes are hanging near their records following a better-than-expected update on inflation. The S&P 500 was up 0.3% early Wednesday and just a bit below its all-time high set...",
    "url": "https://finnhub.io/api/news?id=b6b6d16f6b11ddfaa63cc49e7e857d9b3e63a770d8b01753f2d9548ffd90631f",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752655267,
      "headline": "US stocks hold near all-time highs after a better-than-expected update on inflation",
      "id": 135966798,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "NEW YORK — U.S. stock indexes are hanging near their records following a better-than-expected update on inflation. The S&P 500 was up 0.3% early Wednesday and just a bit below its all-time high set...",
      "url": "https://finnhub.io/api/news?id=b6b6d16f6b11ddfaa63cc49e7e857d9b3e63a770d8b01753f2d9548ffd90631f"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street quietly mixed as corporate earnings pour in, offering a respite from tariff anxiety",
    "summary": "Early trading on Wall Street was quietly mixed on Wednesday as markets shift their attention toward a deluge of corporate earnings reports while monitoring ever-changing developments on U.S. trade...",
    "url": "https://finnhub.io/api/news?id=8d9251545d3619e3eab97418a34a339bd777c74a3374f1f67a21ad3cae680db1",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752655267,
      "headline": "Wall Street quietly mixed as corporate earnings pour in, offering a respite from tariff anxiety",
      "id": 135964526,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Early trading on Wall Street was quietly mixed on Wednesday as markets shift their attention toward a deluge of corporate earnings reports while monitoring ever-changing developments on U.S. trade...",
      "url": "https://finnhub.io/api/news?id=8d9251545d3619e3eab97418a34a339bd777c74a3374f1f67a21ad3cae680db1"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025",
    "summary": "Johnson & Johnson reported earnings results for the second quarter and six months ended June 30, 2025. For the second quarter, the company reported sales was USD 23,743 million compared to USD 22,447...",
    "url": "https://finnhub.io/api/news?id=e904773579c60f73ddb4a48819e18031921d5731bea64e40e97e02bb2dccd60d",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752652290,
      "headline": "Johnson & Johnson Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025",
      "id": 135964148,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Johnson & Johnson reported earnings results for the second quarter and six months ended June 30, 2025. For the second quarter, the company reported sales was USD 23,743 million compared to USD 22,447...",
      "url": "https://finnhub.io/api/news?id=e904773579c60f73ddb4a48819e18031921d5731bea64e40e97e02bb2dccd60d"
    }
  },
  {
    "ts": null,
    "headline": "J&J anticipate second half operational sales growth higher than first half - presentation",
    "summary": "Johnson & Johnson: J&J: anticipate second half operational sales growth higher than first half - presentation J&J: in innovative medicine, negative impact of Part D re-design, as a percent to...",
    "url": "https://finnhub.io/api/news?id=9461a0f7aafb2da3b6e738bb774048749709e9de57e4f34c473a00e23058ce78",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752651852,
      "headline": "J&J anticipate second half operational sales growth higher than first half - presentation",
      "id": 135964093,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Johnson & Johnson: J&J: anticipate second half operational sales growth higher than first half - presentation J&J: in innovative medicine, negative impact of Part D re-design, as a percent to...",
      "url": "https://finnhub.io/api/news?id=9461a0f7aafb2da3b6e738bb774048749709e9de57e4f34c473a00e23058ce78"
    }
  },
  {
    "ts": null,
    "headline": "J&J raises 2025 forecast thanks to promising pipeline",
    "summary": "Johnson & Johnson has announced that its Q2 sales totaled $23.74bn, up 5.8% y-o-y. Net income was $5.5bn , or $2.29 per share . NB: pmt +1.8%.On an adjusted basis, net income was $6.7bn , while EPS...",
    "url": "https://finnhub.io/api/news?id=24968c0feee7d2c6453a042cabe4c3280cf32e42a750c8106a994e5ebaffb6a9",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752650647,
      "headline": "J&J raises 2025 forecast thanks to promising pipeline",
      "id": 135963970,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Johnson & Johnson has announced that its Q2 sales totaled $23.74bn, up 5.8% y-o-y. Net income was $5.5bn , or $2.29 per share . NB: pmt +1.8%.On an adjusted basis, net income was $6.7bn , while EPS...",
      "url": "https://finnhub.io/api/news?id=24968c0feee7d2c6453a042cabe4c3280cf32e42a750c8106a994e5ebaffb6a9"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Revises Sales Guidance for the Full Year of 2025",
    "summary": "Johnson & Johnson revised sales guidance for the full year of 2025. For this period, the company expects operational sales to be in the range of $92.7 billion to $93.1 billion as compared to previous...",
    "url": "https://finnhub.io/api/news?id=b668b76901c8897c78b1e49717087e4f071c388dcc4c85365e2678237bafe473",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752650438,
      "headline": "Johnson & Johnson Revises Sales Guidance for the Full Year of 2025",
      "id": 135963938,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Johnson & Johnson revised sales guidance for the full year of 2025. For this period, the company expects operational sales to be in the range of $92.7 billion to $93.1 billion as compared to previous...",
      "url": "https://finnhub.io/api/news?id=b668b76901c8897c78b1e49717087e4f071c388dcc4c85365e2678237bafe473"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2025, Payable on September 9, 2025",
    "summary": "Johnson & Johnson announced that its Board of Directors has declared a cash dividend for the third quarter of 2025 of $1.30 per share on the company?s common stock. The dividend is payable on...",
    "url": "https://finnhub.io/api/news?id=73c492aa262b4f5b1470ed5564d817a59469b447ab6324f972c50fe1cc8e1560",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752650431,
      "headline": "Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2025, Payable on September 9, 2025",
      "id": 135963940,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Johnson & Johnson announced that its Board of Directors has declared a cash dividend for the third quarter of 2025 of $1.30 per share on the company?s common stock. The dividend is payable on...",
      "url": "https://finnhub.io/api/news?id=73c492aa262b4f5b1470ed5564d817a59469b447ab6324f972c50fe1cc8e1560"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson lifts 2025 forecast, halves tariff cost outlook",
    "summary": "Johnson & Johnson halved itsexpectations for costs this year related to new tariffs andraised its full-year sales and profit forecast on Wednesdayafter a strong quarter for flagship cancer drug...",
    "url": "https://finnhub.io/api/news?id=1c1e303b436046ff608a8fe73c09fdf9bb2d026b232ffcc7b1f5be3455493af3",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752648623,
      "headline": "Johnson & Johnson lifts 2025 forecast, halves tariff cost outlook",
      "id": 135965327,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Johnson & Johnson halved itsexpectations for costs this year related to new tariffs andraised its full-year sales and profit forecast on Wednesdayafter a strong quarter for flagship cancer drug...",
      "url": "https://finnhub.io/api/news?id=1c1e303b436046ff608a8fe73c09fdf9bb2d026b232ffcc7b1f5be3455493af3"
    }
  },
  {
    "ts": null,
    "headline": "J&J Raises Full-Year Outlook After Beating 2Q Expectations",
    "summary": "By Kelly Cloonan Johnson & Johnson boosted its full-year outlook as it posted better-than-expected profit and sales in the second quarter. The healthcare-products company said Tuesday it now...",
    "url": "https://finnhub.io/api/news?id=cb2adc1365084ff7033b72b4be76a4bc4e85c5fdaf08cd4d964c6ccd2be413bf",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752647777,
      "headline": "J&J Raises Full-Year Outlook After Beating 2Q Expectations",
      "id": 135963652,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "By Kelly Cloonan Johnson & Johnson boosted its full-year outlook as it posted better-than-expected profit and sales in the second quarter. The healthcare-products company said Tuesday it now...",
      "url": "https://finnhub.io/api/news?id=cb2adc1365084ff7033b72b4be76a4bc4e85c5fdaf08cd4d964c6ccd2be413bf"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson : 2025 Second-Quarter Infographic & Earnings Presentation",
    "summary": "2nd @uarter 2025 Results ...",
    "url": "https://finnhub.io/api/news?id=8c4839c153a597603c7ffce3df514ff2a8471e9e889e198e199d91030b628139",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752647171,
      "headline": "Johnson & Johnson : 2025 Second-Quarter Infographic & Earnings Presentation",
      "id": 135963593,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "2nd @uarter 2025 Results ...",
      "url": "https://finnhub.io/api/news?id=8c4839c153a597603c7ffce3df514ff2a8471e9e889e198e199d91030b628139"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson : Second Quarter 2025 2Q25 Other Financial Disclosures",
    "summary": "Second Quarter 2025 Other Financial Disclosures Table of Contents ...",
    "url": "https://finnhub.io/api/news?id=5fa79b29e83014db0750721bc88b2febe084bd364ffea024eeb602fa7f45e18a",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752647168,
      "headline": "Johnson & Johnson : Second Quarter 2025 2Q25 Other Financial Disclosures",
      "id": 135963594,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Second Quarter 2025 Other Financial Disclosures Table of Contents ...",
      "url": "https://finnhub.io/api/news?id=5fa79b29e83014db0750721bc88b2febe084bd364ffea024eeb602fa7f45e18a"
    }
  },
  {
    "ts": null,
    "headline": "J&J reports Q2 adjusted EPS $2.77 versus IBES estimate $2.68",
    "summary": "Johnson & Johnson: J&J Q2 adjusted EPS $2.77 versus IBES estimate $2.68 J&J Q2 sales $23.74 billion versus IBES estimate $22.84 billion J&J Q2 Stelara sales $1.65 billion versus IBES estimate...",
    "url": "https://finnhub.io/api/news?id=92db258ba6182e54ac70970d670b4396bd36c4c5a68a0f6426039a39313aa1f2",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752647053,
      "headline": "J&J reports Q2 adjusted EPS $2.77 versus IBES estimate $2.68",
      "id": 135963585,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Johnson & Johnson: J&J Q2 adjusted EPS $2.77 versus IBES estimate $2.68 J&J Q2 sales $23.74 billion versus IBES estimate $22.84 billion J&J Q2 Stelara sales $1.65 billion versus IBES estimate...",
      "url": "https://finnhub.io/api/news?id=92db258ba6182e54ac70970d670b4396bd36c4c5a68a0f6426039a39313aa1f2"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson : 2025 Second-Quarter Press Release & Supplemental Schedules",
    "summary": "Johnson@Johnson Media contact: media-relations@its ini com Investor contact: investor-relations@its ini com For...",
    "url": "https://finnhub.io/api/news?id=b5497781de4dc2381f57adc36c2d0350dcf3db6af27314f7dc7616633236e54e",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752647046,
      "headline": "Johnson & Johnson : 2025 Second-Quarter Press Release & Supplemental Schedules",
      "id": 135963588,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Johnson@Johnson Media contact: media-relations@its ini com Investor contact: investor-relations@its ini com For...",
      "url": "https://finnhub.io/api/news?id=b5497781de4dc2381f57adc36c2d0350dcf3db6af27314f7dc7616633236e54e"
    }
  }
]